• Immunocore appoints David Berman as R&D chief firstwordpharma
    January 16, 2019
    Prior to joining Immunocore, Berman served as senior vice president and head of AstraZeneca's immuno-oncology franchise, holding responsibility for the strategy and execution of the drugmaker's late-stage immuno-oncology programme.
PharmaSources Customer Service